Clin2
NCT07629544Possibly a fitRecruiting

Testing DA-302168S for weight loss in overweight and obese adults

Overweight and Obesity

Part of Hormones & metabolism clinical trials.

This study tests a new medication called DA-302168S to help people lose weight. You may qualify if you're overweight or obese and meet certain health requirements.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
840 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • Age 18–75 years
  • BMI of 28 or higher (obese), or 24–28 with a weight-related health condition like high blood pressure, prediabetes, or joint pain
  • Weight has been stable (changed less than 5%) for the past 3 months while trying diet and exercise
  • No type 1 or type 2 diabetes
  • No history of weight-loss surgery or conditions affecting how your body absorbs medications
  • No recent heart problems, severe psychiatric symptoms, or abnormal blood work

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07845513Not yet recruiting· Phase 1
Study of a new weight-loss medicine in Chinese adults

This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.

Beijing, Beijing Municipality
NCT06252220Recruiting· Phase 1
Testing a new drug for obesity in healthy adults

This trial tests a new medication called DA-1726 for people with obesity but no other major health problems. It aims to see if the drug is safe and how it works in the body. You may qualify if your body mass index (BMI) is between 30 and 45 and your weight has been stable for 3 months.

Miami, Florida
NCT07518589Not yet recruiting· Phase 1
Weight loss drug study for overweight adults

This study tests a new medication called CMS-D008 to see if it can help with weight loss in overweight or obese adults. It is an early-stage trial, so the main goals are to check safety and how the body handles the drug.

NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07009171Recruiting· Phase 2
Testing KDS2010 for weight loss in overweight or obese adults

This study tests a new medication called KDS2010 for people who are overweight or have obesity. The goal is to see if it helps with weight loss when combined with diet and exercise.

Suwon, Gyeonggi-do
NCT07822061Recruiting· Phase 3
Weight loss study for people with excess weight

This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.

Sapporo, Hokkaido

Hear when a new Overweight and Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.